| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 5.66e-23 | 16 | 28 | 9 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.45e-21 | 21 | 28 | 9 | GO:0030228 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.92e-15 | 85 | 28 | 9 | GO:0038024 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 1.57e-07 | 35 | 28 | 4 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 1.57e-07 | 35 | 28 | 4 | GO:0071814 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.10e-07 | 749 | 28 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.77e-06 | 20 | 28 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 1.14e-05 | 4 | 28 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 1.24e-04 | 12 | 28 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | coreceptor activity | 1.38e-04 | 72 | 28 | 3 | GO:0015026 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol binding | 2.55e-04 | 17 | 28 | 2 | GO:0005545 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 2.86e-04 | 18 | 28 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 3.12e-04 | 435 | 28 | 5 | GO:0004857 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 3.86e-04 | 102 | 28 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 1.30e-03 | 596 | 28 | 5 | GO:0140678 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.36e-03 | 39 | 28 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 2.23e-03 | 187 | 28 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | clathrin binding | 3.51e-03 | 63 | 28 | 2 | GO:0030276 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 5.44e-03 | 257 | 28 | 3 | GO:0061134 | |
| GeneOntologyMolecularFunction | amide binding | 8.25e-03 | 299 | 28 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | peptide binding | 9.76e-03 | 318 | 28 | 3 | GO:0042277 | |
| GeneOntologyBiologicalProcess | endocytosis | LRP1 LRP2 LRP3 LRP4 VLDLR LRP12 CD320 LRP10 LRP1B LDLR SORL1 | 2.92e-09 | 827 | 27 | 11 | GO:0006897 |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 7.92e-09 | 337 | 27 | 8 | GO:0006898 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 2.00e-08 | 5 | 27 | 3 | GO:1905167 | |
| GeneOntologyBiologicalProcess | import into cell | LRP1 LRP2 LRP3 LRP4 VLDLR LRP12 CD320 LRP10 LRP1B LDLR SORL1 | 4.37e-08 | 1074 | 27 | 11 | GO:0098657 |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 6.98e-08 | 7 | 27 | 3 | GO:1904352 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 1.12e-07 | 8 | 27 | 3 | GO:0150094 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 2.06e-07 | 40 | 27 | 4 | GO:0097242 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 4.37e-07 | 12 | 27 | 3 | GO:1905165 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 7.21e-07 | 14 | 27 | 3 | GO:1904350 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 3.98e-06 | 24 | 27 | 3 | GO:1905146 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 6.01e-06 | 92 | 27 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 6.41e-06 | 28 | 27 | 3 | GO:0007039 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 1.65e-05 | 5 | 27 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | artery development | 2.58e-05 | 133 | 27 | 4 | GO:0060840 | |
| GeneOntologyBiologicalProcess | negative regulation of ossification | 3.76e-05 | 50 | 27 | 3 | GO:0030279 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 4.46e-05 | 515 | 27 | 6 | GO:0050767 | |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 7.21e-05 | 173 | 27 | 4 | GO:0050768 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 7.38e-05 | 10 | 27 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | cobalamin transport | 7.38e-05 | 10 | 27 | 2 | GO:0015889 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis involved in cholesterol transport | 9.01e-05 | 11 | 27 | 2 | GO:0090118 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 9.16e-05 | 184 | 27 | 4 | GO:0051961 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 1.30e-04 | 625 | 27 | 6 | GO:0051960 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 1.54e-04 | 80 | 27 | 3 | GO:0030514 | |
| GeneOntologyBiologicalProcess | aorta development | 1.54e-04 | 80 | 27 | 3 | GO:0035904 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 1.71e-04 | 83 | 27 | 3 | GO:0060976 | |
| GeneOntologyBiologicalProcess | regulation of triglyceride catabolic process | 1.71e-04 | 15 | 27 | 2 | GO:0010896 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.76e-04 | 218 | 27 | 4 | GO:0090101 | |
| GeneOntologyBiologicalProcess | cholesterol import | 1.96e-04 | 16 | 27 | 2 | GO:0070508 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.97e-04 | 87 | 27 | 3 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 2.04e-04 | 88 | 27 | 3 | GO:0010232 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process | 2.09e-04 | 228 | 27 | 4 | GO:0045732 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 3.43e-04 | 105 | 27 | 3 | GO:0048708 | |
| GeneOntologyBiologicalProcess | transcytosis | 4.47e-04 | 24 | 27 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | lipid transport | 4.50e-04 | 506 | 27 | 5 | GO:0006869 | |
| GeneOntologyBiologicalProcess | spinal cord development | 4.95e-04 | 119 | 27 | 3 | GO:0021510 | |
| GeneOntologyBiologicalProcess | lipoprotein transport | 6.11e-04 | 28 | 27 | 2 | GO:0042953 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 6.55e-04 | 131 | 27 | 3 | GO:0030510 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 6.56e-04 | 29 | 27 | 2 | GO:0044872 | |
| GeneOntologyBiologicalProcess | astrocyte activation | 6.56e-04 | 29 | 27 | 2 | GO:0048143 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 6.83e-04 | 1194 | 27 | 7 | GO:0000902 | |
| GeneOntologyBiologicalProcess | cholesterol transport | 7.00e-04 | 134 | 27 | 3 | GO:0030301 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 7.00e-04 | 134 | 27 | 3 | GO:0003279 | |
| GeneOntologyBiologicalProcess | triglyceride catabolic process | 7.02e-04 | 30 | 27 | 2 | GO:0019433 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | 7.38e-04 | 864 | 27 | 6 | GO:0051129 | |
| GeneOntologyBiologicalProcess | lipid localization | 7.42e-04 | 565 | 27 | 5 | GO:0010876 | |
| GeneOntologyBiologicalProcess | positive regulation of viral genome replication | 7.50e-04 | 31 | 27 | 2 | GO:0045070 | |
| GeneOntologyBiologicalProcess | sterol transport | 7.78e-04 | 139 | 27 | 3 | GO:0015918 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 9.02e-04 | 34 | 27 | 2 | GO:0060977 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | 9.09e-04 | 591 | 27 | 5 | GO:1903829 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 9.15e-04 | 147 | 27 | 3 | GO:0030278 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 9.70e-04 | 150 | 27 | 3 | GO:0090288 | |
| GeneOntologyBiologicalProcess | regulation of gliogenesis | 9.89e-04 | 151 | 27 | 3 | GO:0014013 | |
| GeneOntologyBiologicalProcess | heart formation | 1.01e-03 | 36 | 27 | 2 | GO:0060914 | |
| GeneOntologyBiologicalProcess | intracellular cholesterol transport | 1.01e-03 | 36 | 27 | 2 | GO:0032367 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.02e-03 | 347 | 27 | 4 | GO:0090092 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 1.08e-03 | 353 | 27 | 4 | GO:0010721 | |
| GeneOntologyBiologicalProcess | female sex differentiation | 1.11e-03 | 157 | 27 | 3 | GO:0046660 | |
| GeneOntologyBiologicalProcess | intracellular sterol transport | 1.19e-03 | 39 | 27 | 2 | GO:0032366 | |
| GeneOntologyBiologicalProcess | negative regulation of glial cell differentiation | 1.19e-03 | 39 | 27 | 2 | GO:0045686 | |
| GeneOntologyBiologicalProcess | cholesterol metabolic process | 1.23e-03 | 163 | 27 | 3 | GO:0008203 | |
| GeneOntologyBiologicalProcess | neutral lipid catabolic process | 1.31e-03 | 41 | 27 | 2 | GO:0046461 | |
| GeneOntologyBiologicalProcess | acylglycerol catabolic process | 1.31e-03 | 41 | 27 | 2 | GO:0046464 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 1.31e-03 | 41 | 27 | 2 | GO:0035909 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 1.37e-03 | 376 | 27 | 4 | GO:0008202 | |
| GeneOntologyBiologicalProcess | regulation of astrocyte differentiation | 1.44e-03 | 43 | 27 | 2 | GO:0048710 | |
| GeneOntologyBiologicalProcess | secondary alcohol metabolic process | 1.54e-03 | 176 | 27 | 3 | GO:1902652 | |
| GeneOntologyBiologicalProcess | sterol metabolic process | 1.56e-03 | 177 | 27 | 3 | GO:0016125 | |
| GeneOntologyBiologicalProcess | astrocyte development | 1.72e-03 | 47 | 27 | 2 | GO:0014002 | |
| GeneOntologyBiologicalProcess | intestinal absorption | 1.72e-03 | 47 | 27 | 2 | GO:0050892 | |
| GeneOntologyBiologicalProcess | tube formation | 1.83e-03 | 187 | 27 | 3 | GO:0035148 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process | 1.83e-03 | 407 | 27 | 4 | GO:0042176 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 1.91e-03 | 412 | 27 | 4 | GO:0006066 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.91e-03 | 412 | 27 | 4 | GO:0090287 | |
| GeneOntologyBiologicalProcess | positive regulation of catabolic process | 1.94e-03 | 701 | 27 | 5 | GO:0009896 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway | 2.06e-03 | 195 | 27 | 3 | GO:0030178 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 2.12e-03 | 197 | 27 | 3 | GO:0030509 | |
| GeneOntologyBiologicalProcess | intracellular lipid transport | 2.18e-03 | 53 | 27 | 2 | GO:0032365 | |
| GeneOntologyBiologicalProcess | neural tube development | 2.28e-03 | 202 | 27 | 3 | GO:0021915 | |
| GeneOntologyBiologicalProcess | gliogenesis | 2.33e-03 | 435 | 27 | 4 | GO:0042063 | |
| GeneOntologyBiologicalProcess | receptor recycling | 2.35e-03 | 55 | 27 | 2 | GO:0001881 | |
| GeneOntologyBiologicalProcess | vitamin transport | 2.43e-03 | 56 | 27 | 2 | GO:0051180 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 2.50e-03 | 1095 | 27 | 6 | GO:0060284 | |
| GeneOntologyBiologicalProcess | ventral spinal cord development | 2.52e-03 | 57 | 27 | 2 | GO:0021517 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 2.53e-03 | 445 | 27 | 4 | GO:0141091 | |
| GeneOntologyBiologicalProcess | intracellular transport | 2.54e-03 | 1496 | 27 | 7 | GO:0046907 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 2.57e-03 | 748 | 27 | 5 | GO:0048667 | |
| GeneOntologyBiologicalProcess | regulation of triglyceride metabolic process | 2.61e-03 | 58 | 27 | 2 | GO:0090207 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 2.61e-03 | 212 | 27 | 3 | GO:0003205 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.34e-11 | 80 | 29 | 7 | GO:0005905 | |
| GeneOntologyCellularComponent | cell surface | LRP1 LRP2 LRP4 CORIN VLDLR GFRA4 UMODL1 LDLR ST14 CD163L1 NOTCH1 SORL1 | 1.07e-08 | 1111 | 29 | 12 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | 5.42e-06 | 519 | 29 | 7 | GO:0009897 | |
| GeneOntologyCellularComponent | receptor complex | 1.13e-05 | 581 | 29 | 7 | GO:0043235 | |
| GeneOntologyCellularComponent | side of membrane | 1.79e-05 | 875 | 29 | 8 | GO:0098552 | |
| GeneOntologyCellularComponent | vacuolar membrane | 6.04e-04 | 507 | 29 | 5 | GO:0005774 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 9.46e-04 | 320 | 29 | 4 | GO:0016323 | |
| GeneOntologyCellularComponent | plasma membrane raft | 1.09e-03 | 147 | 29 | 3 | GO:0044853 | |
| GeneOntologyCellularComponent | apical part of cell | 1.21e-03 | 592 | 29 | 5 | GO:0045177 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.37e-03 | 354 | 29 | 4 | GO:0009925 | |
| GeneOntologyCellularComponent | lipoprotein particle | 1.70e-03 | 44 | 29 | 2 | GO:1990777 | |
| GeneOntologyCellularComponent | plasma lipoprotein particle | 1.70e-03 | 44 | 29 | 2 | GO:0034358 | |
| GeneOntologyCellularComponent | basal part of cell | 1.75e-03 | 378 | 29 | 4 | GO:0045178 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.77e-03 | 45 | 29 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | protein-lipid complex | 1.93e-03 | 47 | 29 | 2 | GO:0032994 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 3.09e-03 | 212 | 29 | 3 | GO:0030666 | |
| GeneOntologyCellularComponent | lysosomal membrane | 3.61e-03 | 462 | 29 | 4 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 3.61e-03 | 462 | 29 | 4 | GO:0098852 | |
| GeneOntologyCellularComponent | early endosome | 4.17e-03 | 481 | 29 | 4 | GO:0005769 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 4.23e-03 | 237 | 29 | 3 | GO:0030136 | |
| GeneOntologyCellularComponent | endosome | 4.69e-03 | 1167 | 29 | 6 | GO:0005768 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 5.36e-03 | 79 | 29 | 2 | GO:0030669 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 6.00e-03 | 1228 | 29 | 6 | GO:0036477 | |
| GeneOntologyCellularComponent | vacuole | 7.80e-03 | 913 | 29 | 5 | GO:0005773 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 8.62e-03 | 101 | 29 | 2 | GO:0045334 | |
| GeneOntologyCellularComponent | caveola | 1.03e-02 | 111 | 29 | 2 | GO:0005901 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 1.05e-02 | 112 | 29 | 2 | GO:0055038 | |
| Domain | LDLR_class-A_CS | LRP1 LRP2 LRP3 LRP4 DGCR2 CORIN VLDLR LRP12 CD320 LRP10 SSPOP LRP1B LDLR ST14 SORL1 | 3.43e-34 | 40 | 29 | 15 | IPR023415 |
| Domain | Ldl_recept_a | LRP1 LRP2 LRP3 LRP4 DGCR2 CORIN VLDLR LRP12 CD320 LRP10 SSPOP LRP1B LDLR ST14 SORL1 | 2.93e-33 | 45 | 29 | 15 | PF00057 |
| Domain | - | LRP1 LRP2 LRP3 LRP4 DGCR2 CORIN VLDLR LRP12 CD320 LRP10 SSPOP LRP1B LDLR ST14 SORL1 | 4.35e-33 | 46 | 29 | 15 | 4.10.400.10 |
| Domain | LDLRA_1 | LRP1 LRP2 LRP3 LRP4 DGCR2 CORIN VLDLR LRP12 CD320 LRP10 SSPOP LRP1B LDLR ST14 SORL1 | 9.28e-33 | 48 | 29 | 15 | PS01209 |
| Domain | LDrepeatLR_classA_rpt | LRP1 LRP2 LRP3 LRP4 DGCR2 CORIN VLDLR LRP12 CD320 LRP10 SSPOP LRP1B LDLR ST14 SORL1 | 1.34e-32 | 49 | 29 | 15 | IPR002172 |
| Domain | LDLa | LRP1 LRP2 LRP3 LRP4 DGCR2 CORIN VLDLR LRP12 CD320 LRP10 SSPOP LRP1B LDLR ST14 SORL1 | 1.34e-32 | 49 | 29 | 15 | SM00192 |
| Domain | LDLRA_2 | LRP1 LRP2 LRP3 LRP4 DGCR2 CORIN VLDLR LRP12 CD320 LRP10 SSPOP LRP1B LDLR ST14 SORL1 | 1.34e-32 | 49 | 29 | 15 | PS50068 |
| Domain | Ldl_recept_b | 3.38e-17 | 14 | 29 | 7 | PF00058 | |
| Domain | LDLRB | 3.38e-17 | 14 | 29 | 7 | PS51120 | |
| Domain | LY | 6.34e-17 | 15 | 29 | 7 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.34e-17 | 15 | 29 | 7 | IPR000033 | |
| Domain | EGF_3 | LRP1 LRP2 LRP4 VLDLR UMODL1 SSPOP LRP1B LDLR NOTCH1 TMEFF2 SORL1 | 2.81e-14 | 235 | 29 | 11 | PS50026 |
| Domain | EGF_2 | LRP1 LRP2 LRP4 VLDLR UMODL1 SSPOP LRP1B LDLR NOTCH1 TMEFF2 SORL1 | 1.05e-13 | 265 | 29 | 11 | PS01186 |
| Domain | - | 1.48e-13 | 39 | 29 | 7 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 5.11e-13 | 46 | 29 | 7 | IPR011042 | |
| Domain | EGF_CA | 5.74e-13 | 86 | 29 | 8 | PF07645 | |
| Domain | EGF | 1.33e-12 | 235 | 29 | 10 | SM00181 | |
| Domain | EGF_Ca-bd_CS | 1.55e-12 | 97 | 29 | 8 | IPR018097 | |
| Domain | EGF_CA | 1.83e-12 | 99 | 29 | 8 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.99e-12 | 100 | 29 | 8 | PS00010 | |
| Domain | EGF-like_dom | 2.37e-12 | 249 | 29 | 10 | IPR000742 | |
| Domain | EGF_1 | 3.01e-12 | 255 | 29 | 10 | PS00022 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.20e-12 | 106 | 29 | 8 | IPR000152 | |
| Domain | EGF-like_CS | 3.79e-12 | 261 | 29 | 10 | IPR013032 | |
| Domain | EGF_CA | 1.01e-11 | 122 | 29 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.15e-11 | 124 | 29 | 8 | IPR001881 | |
| Domain | Growth_fac_rcpt_ | 7.31e-11 | 156 | 29 | 8 | IPR009030 | |
| Domain | EGF | 7.42e-10 | 126 | 29 | 7 | PF00008 | |
| Domain | cEGF | 6.84e-08 | 26 | 29 | 4 | IPR026823 | |
| Domain | cEGF | 6.84e-08 | 26 | 29 | 4 | PF12662 | |
| Domain | CUB | 9.46e-07 | 49 | 29 | 4 | PF00431 | |
| Domain | CUB | 1.03e-06 | 50 | 29 | 4 | SM00042 | |
| Domain | - | 1.21e-06 | 52 | 29 | 4 | 2.60.120.290 | |
| Domain | CUB | 1.30e-06 | 53 | 29 | 4 | PS01180 | |
| Domain | CUB_dom | 1.75e-06 | 57 | 29 | 4 | IPR000859 | |
| Domain | DUF5050 | 2.33e-06 | 2 | 29 | 2 | IPR032485 | |
| Domain | DUF5050 | 2.33e-06 | 2 | 29 | 2 | PF16472 | |
| Domain | EGF_extracell | 1.09e-04 | 60 | 29 | 3 | IPR013111 | |
| Domain | EGF_2 | 1.09e-04 | 60 | 29 | 3 | PF07974 | |
| Domain | TIL_dom | 2.09e-04 | 14 | 29 | 2 | IPR002919 | |
| Domain | EMI | 3.12e-04 | 17 | 29 | 2 | PS51041 | |
| Domain | WAP_dom | 5.27e-04 | 22 | 29 | 2 | IPR008197 | |
| Domain | SEA | 5.27e-04 | 22 | 29 | 2 | PF01390 | |
| Domain | SEA | 5.77e-04 | 23 | 29 | 2 | PS50024 | |
| Domain | SEA_dom | 5.77e-04 | 23 | 29 | 2 | IPR000082 | |
| Domain | SR | 6.83e-04 | 25 | 29 | 2 | SM00202 | |
| Domain | SRCR_1 | 7.39e-04 | 26 | 29 | 2 | PS00420 | |
| Domain | SRCR-like_dom | 7.39e-04 | 26 | 29 | 2 | IPR017448 | |
| Domain | SRCR_2 | 7.39e-04 | 26 | 29 | 2 | PS50287 | |
| Domain | SRCR | 7.98e-04 | 27 | 29 | 2 | IPR001190 | |
| Domain | VWFC_1 | 1.42e-03 | 36 | 29 | 2 | PS01208 | |
| Domain | VWC | 1.58e-03 | 38 | 29 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.58e-03 | 38 | 29 | 2 | PS50184 | |
| Domain | VWF_dom | 1.93e-03 | 42 | 29 | 2 | IPR001007 | |
| Domain | TRYPSIN_SER | 8.57e-03 | 90 | 29 | 2 | IPR033116 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | LRP1 LRP2 LRP3 LRP4 VLDLR LRP12 CD320 LRP10 LRP1B LDLR CD163L1 SORL1 | 1.54e-12 | 381 | 27 | 12 | M48063 |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.82e-08 | 48 | 27 | 5 | M27642 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.16e-06 | 100 | 27 | 5 | M27158 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.51e-06 | 45 | 27 | 4 | MM15344 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 1.65e-06 | 198 | 27 | 6 | M18311 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 1.77e-06 | 13 | 27 | 3 | M42551 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 2.61e-05 | 189 | 27 | 5 | MM14772 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 2.66e-05 | 92 | 27 | 4 | MM14881 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 7.38e-05 | 7 | 27 | 2 | MM15703 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 9.82e-05 | 8 | 27 | 2 | M45025 | |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 3.65e-04 | 15 | 27 | 2 | MM14762 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5 | 3.65e-04 | 15 | 27 | 2 | M42552 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 4.40e-04 | 190 | 27 | 4 | MM15687 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1 | 5.30e-04 | 18 | 27 | 2 | M42559 | |
| Pathway | WP_STATIN_PATHWAY | 5.92e-04 | 19 | 27 | 2 | MM15868 | |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 7.97e-04 | 22 | 27 | 2 | M27084 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4 | 7.97e-04 | 22 | 27 | 2 | M42574 | |
| Pathway | WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION | 1.59e-03 | 31 | 27 | 2 | M39514 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 1.91e-03 | 34 | 27 | 2 | MM15566 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 2.26e-03 | 37 | 27 | 2 | M27847 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 2.90e-03 | 42 | 27 | 2 | M174 | |
| Pathway | PID_PS1_PATHWAY | 3.47e-03 | 46 | 27 | 2 | M70 | |
| Pubmed | 3.36e-16 | 5 | 30 | 5 | 19047013 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.30e-14 | 21 | 30 | 6 | 21337463 | |
| Pubmed | 2.25e-12 | 5 | 30 | 4 | 18685438 | ||
| Pubmed | 1.57e-11 | 7 | 30 | 4 | 12169628 | ||
| Pubmed | 5.65e-11 | 9 | 30 | 4 | 20005821 | ||
| Pubmed | 1.48e-10 | 11 | 30 | 4 | 24639464 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.90e-10 | 101 | 30 | 6 | 23382219 | |
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 4.47e-10 | 14 | 30 | 4 | 17389516 | |
| Pubmed | 4.47e-10 | 14 | 30 | 4 | 15082773 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 18367731 | ||
| Pubmed | 1.36e-09 | 18 | 30 | 4 | 10827173 | ||
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 21273557 | ||
| Pubmed | Developmental regulation of LR11 expression in murine brain. | 2.32e-09 | 4 | 30 | 3 | 9726247 | |
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 15863833 | ||
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 15840700 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | LRP1 LRP4 DGCR2 LRP12 CD320 TOR3A LRP10 LRP1B LDLR NOTCH1 SORL1 | 2.38e-09 | 1201 | 30 | 11 | 35696571 |
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 8013374 | ||
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 30700132 | ||
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 12746448 | ||
| Pubmed | Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo. | 5.78e-09 | 5 | 30 | 3 | 18992221 | |
| Pubmed | Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. | 5.78e-09 | 5 | 30 | 3 | 23959870 | |
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 9837937 | ||
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 16478678 | ||
| Pubmed | 3.23e-08 | 8 | 30 | 3 | 10380922 | ||
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 4.85e-08 | 9 | 30 | 3 | 7544347 | |
| Pubmed | 4.20e-07 | 71 | 30 | 4 | 33541421 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 7.19e-07 | 2 | 30 | 2 | 15963947 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17505534 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 34445520 | ||
| Pubmed | Maternofetal transport of vitamin B12: role of TCblR/CD320 and megalin. | 7.19e-07 | 2 | 30 | 2 | 28351841 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19393635 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17889283 | ||
| Pubmed | Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. | 7.19e-07 | 2 | 30 | 2 | 11971949 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 33913039 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10024503 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20005200 | ||
| Pubmed | LRP: role in vascular wall integrity and protection from atherosclerosis. | 7.19e-07 | 2 | 30 | 2 | 12690199 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11108739 | ||
| Pubmed | Clearance of coagulation factor VIII in very low-density lipoprotein receptor knockout mice. | 7.19e-07 | 2 | 30 | 2 | 15327526 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10575007 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23430977 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17709443 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9449704 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 16723719 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 8636110 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 25546260 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18277139 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23846497 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 31796057 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 19667105 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 14583618 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 21730304 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 26323289 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18990694 | ||
| Pubmed | Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. | 2.16e-06 | 3 | 30 | 2 | 17303763 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 30100244 | ||
| Pubmed | RAGE, LDL receptor, and LRP1 expression in the brains of SAMP8. | 2.16e-06 | 3 | 30 | 2 | 19539695 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 11931574 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23675525 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 14739216 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 10488949 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 28799085 | ||
| Pubmed | Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report. | 2.16e-06 | 3 | 30 | 2 | 30567480 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18369154 | ||
| Pubmed | Gene expression related to cholesterol metabolism in mouse brain during development. | 2.16e-06 | 3 | 30 | 2 | 10891640 | |
| Pubmed | LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages. | 2.16e-06 | 3 | 30 | 2 | 26061292 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 1423604 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 19742316 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 7959795 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.18e-06 | 1105 | 30 | 8 | 35748872 | |
| Pubmed | 3.42e-06 | 1116 | 30 | 8 | 31753913 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 27522265 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 20093106 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 22174911 | ||
| Pubmed | apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. | 4.31e-06 | 4 | 30 | 2 | 19033669 | |
| Pubmed | Apolipoprotein E isoform-specific effects on lipoprotein receptor processing. | 4.31e-06 | 4 | 30 | 2 | 25015123 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 12413896 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 34118252 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 18566402 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 31108099 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 27365402 | ||
| Pubmed | Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. | 4.31e-06 | 4 | 30 | 2 | 9555943 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 17038633 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 17080197 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 20030366 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 10571240 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 7775583 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 27453008 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 11421580 | ||
| Pubmed | Brown adipose tissue activity controls triglyceride clearance. | 4.31e-06 | 4 | 30 | 2 | 21258337 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 22109552 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 20360257 | ||
| Pubmed | LRP1 controls cPLA2 phosphorylation, ABCA1 expression and cellular cholesterol export. | 4.31e-06 | 4 | 30 | 2 | 19718435 | |
| Pubmed | Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice. | 4.31e-06 | 4 | 30 | 2 | 9788969 | |
| Pubmed | Selective expression of LDLR and VLDLR in myelinating oligodendrocytes. | 4.31e-06 | 4 | 30 | 2 | 17685481 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 23283348 | ||
| Pubmed | 5.03e-06 | 132 | 30 | 4 | 26439863 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 17055779 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 20383322 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 16101684 | ||
| Interaction | IGFL3 interactions | 1.12e-15 | 75 | 30 | 9 | int:IGFL3 | |
| Interaction | NTN5 interactions | 8.44e-13 | 24 | 30 | 6 | int:NTN5 | |
| Interaction | TIMP3 interactions | 5.23e-11 | 90 | 30 | 7 | int:TIMP3 | |
| Interaction | ZFP41 interactions | 2.20e-10 | 57 | 30 | 6 | int:ZFP41 | |
| Interaction | ANKRD36B interactions | 3.03e-10 | 60 | 30 | 6 | int:ANKRD36B | |
| Interaction | LRPAP1 interactions | 6.90e-09 | 180 | 30 | 7 | int:LRPAP1 | |
| Interaction | DEFB123 interactions | 7.17e-09 | 16 | 30 | 4 | int:DEFB123 | |
| Interaction | ZNF224 interactions | 1.90e-08 | 20 | 30 | 4 | int:ZNF224 | |
| Interaction | EGFL6 interactions | 2.35e-08 | 21 | 30 | 4 | int:EGFL6 | |
| Interaction | ZNF408 interactions | 6.44e-08 | 145 | 30 | 6 | int:ZNF408 | |
| Interaction | CLEC2B interactions | 6.99e-08 | 147 | 30 | 6 | int:CLEC2B | |
| Interaction | FEZF1 interactions | 7.97e-08 | 28 | 30 | 4 | int:FEZF1 | |
| Interaction | DLK2 interactions | 2.27e-07 | 36 | 30 | 4 | int:DLK2 | |
| Interaction | DAB1 interactions | 4.92e-07 | 107 | 30 | 5 | int:DAB1 | |
| Interaction | ZNF563 interactions | 6.49e-07 | 12 | 30 | 3 | int:ZNF563 | |
| Interaction | LYZL1 interactions | 8.01e-07 | 118 | 30 | 5 | int:LYZL1 | |
| Interaction | WNT3A interactions | 8.07e-07 | 49 | 30 | 4 | int:WNT3A | |
| Interaction | DKK2 interactions | 8.07e-07 | 49 | 30 | 4 | int:DKK2 | |
| Interaction | FOXD4L6 interactions | 8.07e-07 | 49 | 30 | 4 | int:FOXD4L6 | |
| Interaction | ZDHHC15 interactions | 1.07e-06 | 125 | 30 | 5 | int:ZDHHC15 | |
| Interaction | IGSF5 interactions | 1.07e-06 | 14 | 30 | 3 | int:IGSF5 | |
| Interaction | CFC1 interactions | 1.11e-06 | 126 | 30 | 5 | int:CFC1 | |
| Interaction | FBXO2 interactions | 1.89e-06 | 411 | 30 | 7 | int:FBXO2 | |
| Interaction | ZNF331 interactions | 2.24e-06 | 63 | 30 | 4 | int:ZNF331 | |
| Interaction | CCN6 interactions | 2.84e-06 | 19 | 30 | 3 | int:CCN6 | |
| Interaction | P2RX2 interactions | 3.42e-06 | 70 | 30 | 4 | int:P2RX2 | |
| Interaction | APOE interactions | 4.98e-06 | 171 | 30 | 5 | int:APOE | |
| Interaction | EGFL7 interactions | 5.01e-06 | 77 | 30 | 4 | int:EGFL7 | |
| Interaction | TAFA3 interactions | 5.27e-06 | 78 | 30 | 4 | int:TAFA3 | |
| Interaction | GOLGA8G interactions | 5.90e-06 | 24 | 30 | 3 | int:GOLGA8G | |
| Interaction | SNX17 interactions | 6.13e-06 | 81 | 30 | 4 | int:SNX17 | |
| Interaction | LRP1B interactions | 7.43e-06 | 85 | 30 | 4 | int:LRP1B | |
| Interaction | ZNF517 interactions | 1.06e-05 | 29 | 30 | 3 | int:ZNF517 | |
| Interaction | ZNF74 interactions | 1.73e-05 | 34 | 30 | 3 | int:ZNF74 | |
| Interaction | TMPRSS13 interactions | 1.78e-05 | 106 | 30 | 4 | int:TMPRSS13 | |
| Interaction | LPL interactions | 1.89e-05 | 35 | 30 | 3 | int:LPL | |
| Interaction | SOST interactions | 1.89e-05 | 35 | 30 | 3 | int:SOST | |
| Interaction | EDN3 interactions | 1.92e-05 | 108 | 30 | 4 | int:EDN3 | |
| Interaction | GREM2 interactions | 2.24e-05 | 37 | 30 | 3 | int:GREM2 | |
| Interaction | LDLRAP1 interactions | 2.24e-05 | 37 | 30 | 3 | int:LDLRAP1 | |
| Interaction | VLDLR interactions | 2.62e-05 | 39 | 30 | 3 | int:VLDLR | |
| Interaction | CMA1 interactions | 4.33e-05 | 46 | 30 | 3 | int:CMA1 | |
| Interaction | ECEL1 interactions | 4.48e-05 | 134 | 30 | 4 | int:ECEL1 | |
| Interaction | PRG2 interactions | 5.82e-05 | 285 | 30 | 5 | int:PRG2 | |
| Interaction | HGF interactions | 5.91e-05 | 51 | 30 | 3 | int:HGF | |
| Interaction | TYW3 interactions | 6.63e-05 | 53 | 30 | 3 | int:TYW3 | |
| Interaction | SERPINE1 interactions | 7.01e-05 | 54 | 30 | 3 | int:SERPINE1 | |
| Interaction | ADAM30 interactions | 7.82e-05 | 56 | 30 | 3 | int:ADAM30 | |
| Interaction | UGT1A7 interactions | 8.25e-05 | 57 | 30 | 3 | int:UGT1A7 | |
| Interaction | KLRC1 interactions | 9.59e-05 | 163 | 30 | 4 | int:KLRC1 | |
| Interaction | PLAT interactions | 1.11e-04 | 63 | 30 | 3 | int:PLAT | |
| Interaction | IFNAR1 interactions | 1.17e-04 | 64 | 30 | 3 | int:IFNAR1 | |
| Interaction | LIPG interactions | 1.17e-04 | 64 | 30 | 3 | int:LIPG | |
| Interaction | NRSN1 interactions | 1.38e-04 | 179 | 30 | 4 | int:NRSN1 | |
| Interaction | MARCHF1 interactions | 1.52e-04 | 70 | 30 | 3 | int:MARCHF1 | |
| Interaction | ZNF584 interactions | 1.65e-04 | 13 | 30 | 2 | int:ZNF584 | |
| Interaction | RNASE4 interactions | 1.93e-04 | 14 | 30 | 2 | int:RNASE4 | |
| Interaction | MRAP2 interactions | 2.02e-04 | 77 | 30 | 3 | int:MRAP2 | |
| Interaction | ZNF707 interactions | 2.18e-04 | 79 | 30 | 3 | int:ZNF707 | |
| Interaction | ADAM33 interactions | 2.18e-04 | 79 | 30 | 3 | int:ADAM33 | |
| Interaction | DNAJB9 interactions | 2.19e-04 | 202 | 30 | 4 | int:DNAJB9 | |
| Interaction | RSPO1 interactions | 2.22e-04 | 15 | 30 | 2 | int:RSPO1 | |
| Interaction | CUBN interactions | 2.22e-04 | 15 | 30 | 2 | int:CUBN | |
| Interaction | ST14 interactions | 2.40e-04 | 207 | 30 | 4 | int:ST14 | |
| Interaction | TAFAZZIN interactions | 2.40e-04 | 207 | 30 | 4 | int:TAFAZZIN | |
| Interaction | PI15 interactions | 2.52e-04 | 83 | 30 | 3 | int:PI15 | |
| Interaction | ZNF816 interactions | 2.54e-04 | 16 | 30 | 2 | int:ZNF816 | |
| Interaction | SCN3A interactions | 2.54e-04 | 16 | 30 | 2 | int:SCN3A | |
| Interaction | GGA2 interactions | 2.61e-04 | 84 | 30 | 3 | int:GGA2 | |
| Interaction | SIRPD interactions | 2.80e-04 | 86 | 30 | 3 | int:SIRPD | |
| Interaction | RGS9BP interactions | 3.23e-04 | 18 | 30 | 2 | int:RGS9BP | |
| Interaction | MDK interactions | 3.31e-04 | 91 | 30 | 3 | int:MDK | |
| Interaction | ELSPBP1 interactions | 3.42e-04 | 92 | 30 | 3 | int:ELSPBP1 | |
| Interaction | CTSG interactions | 3.76e-04 | 95 | 30 | 3 | int:CTSG | |
| Interaction | CLU interactions | 4.56e-04 | 245 | 30 | 4 | int:CLU | |
| Interaction | SYT1 interactions | 5.04e-04 | 105 | 30 | 3 | int:SYT1 | |
| Interaction | FURIN interactions | 5.30e-04 | 255 | 30 | 4 | int:FURIN | |
| Interaction | WNT2 interactions | 5.32e-04 | 23 | 30 | 2 | int:WNT2 | |
| Interaction | WWP1 interactions | 5.70e-04 | 260 | 30 | 4 | int:WWP1 | |
| Interaction | SULF2 interactions | 7.25e-04 | 119 | 30 | 3 | int:SULF2 | |
| Interaction | PID1 interactions | 7.35e-04 | 27 | 30 | 2 | int:PID1 | |
| Interaction | ENTREP3 interactions | 7.43e-04 | 120 | 30 | 3 | int:ENTREP3 | |
| Interaction | NCR3 interactions | 7.43e-04 | 120 | 30 | 3 | int:NCR3 | |
| Interaction | GGA1 interactions | 7.61e-04 | 121 | 30 | 3 | int:GGA1 | |
| Interaction | GPR17 interactions | 7.82e-04 | 283 | 30 | 4 | int:GPR17 | |
| Interaction | LYPD4 interactions | 7.99e-04 | 123 | 30 | 3 | int:LYPD4 | |
| Interaction | GLI4 interactions | 8.37e-04 | 125 | 30 | 3 | int:GLI4 | |
| Interaction | ZNF354C interactions | 8.48e-04 | 29 | 30 | 2 | int:ZNF354C | |
| Interaction | ZSCAN21 interactions | 8.96e-04 | 128 | 30 | 3 | int:ZSCAN21 | |
| Interaction | ALG12 interactions | 9.70e-04 | 31 | 30 | 2 | int:ALG12 | |
| Interaction | ZBBX interactions | 9.70e-04 | 31 | 30 | 2 | int:ZBBX | |
| Interaction | ASIC4 interactions | 1.02e-03 | 134 | 30 | 3 | int:ASIC4 | |
| Interaction | FST interactions | 1.03e-03 | 32 | 30 | 2 | int:FST | |
| Interaction | ALG6 interactions | 1.03e-03 | 32 | 30 | 2 | int:ALG6 | |
| Interaction | OGFOD3 interactions | 1.03e-03 | 32 | 30 | 2 | int:OGFOD3 | |
| Interaction | TOP3B interactions | 1.08e-03 | 1470 | 30 | 8 | int:TOP3B | |
| Interaction | ITGB1BP1 interactions | 1.10e-03 | 33 | 30 | 2 | int:ITGB1BP1 | |
| Interaction | GCNT1 interactions | 1.10e-03 | 33 | 30 | 2 | int:GCNT1 | |
| Interaction | SPINT2 interactions | 1.11e-03 | 138 | 30 | 3 | int:SPINT2 | |
| Interaction | DAB2 interactions | 1.16e-03 | 140 | 30 | 3 | int:DAB2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 6.94e-03 | 191 | 30 | 2 | chr11q24 | |
| GeneFamily | Low density lipoprotein receptors | 6.25e-25 | 13 | 22 | 9 | 634 | |
| GeneFamily | Proteases, serine | 2.64e-03 | 63 | 22 | 2 | 738 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 1.62e-05 | 43 | 30 | 3 | MM666 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 1.62e-05 | 43 | 30 | 3 | M1551 | |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_k-means-cluster#3_top-relative-expression-ranked_500 | 5.02e-06 | 84 | 29 | 4 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | 9.19e-06 | 811 | 29 | 8 | gudmap_developingKidney_e15.5_S-shaped body_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.70e-05 | 148 | 29 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_500 | 1.68e-04 | 390 | 29 | 5 | gudmap_developingKidney_e15.5_cortic collect duct_500 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.58e-06 | 195 | 30 | 4 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.58e-06 | 195 | 30 | 4 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.30e-06 | 199 | 30 | 4 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 1.55e-04 | 156 | 30 | 3 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 163 | 30 | 3 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 163 | 30 | 3 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-04 | 166 | 30 | 3 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue | 1.93e-04 | 168 | 30 | 3 | d5b746d6083c2c8155a0ea345ea368bf6617d5ca | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 170 | 30 | 3 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 174 | 30 | 3 | b2fc2a756f8e373ad903bd416d9de703d945fa1c | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 174 | 30 | 3 | 0fccd90ef72ec2e5eb369fe6d6d126c60886485a | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 2.25e-04 | 177 | 30 | 3 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.25e-04 | 177 | 30 | 3 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.36e-04 | 180 | 30 | 3 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 2.36e-04 | 180 | 30 | 3 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | droplet-Limb_Muscle-nan-21m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 182 | 30 | 3 | a51cbdb8d6528a82044be838c70c492fc6370891 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.56e-04 | 185 | 30 | 3 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed | |
| ToppCell | facs-Lung-EPCAM-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 186 | 30 | 3 | 7c4eb769574f9f32753cea1cc38c711dabba88b9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.64e-04 | 187 | 30 | 3 | 5917bdfe84cf5941e21b415aebbab3090cc5d576 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 188 | 30 | 3 | 2cfa41c64eccb28b5e22f0f91bbc921b75713245 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.68e-04 | 188 | 30 | 3 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 189 | 30 | 3 | 0a8b827bba1efd885ad6c06929251c741dc3a541 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-04 | 189 | 30 | 3 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-04 | 189 | 30 | 3 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.72e-04 | 189 | 30 | 3 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-04 | 189 | 30 | 3 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 189 | 30 | 3 | 6e52cac679e0541ca5f2be316bdabdbc34da6e18 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-04 | 190 | 30 | 3 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.77e-04 | 190 | 30 | 3 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 2.77e-04 | 190 | 30 | 3 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.81e-04 | 191 | 30 | 3 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.81e-04 | 191 | 30 | 3 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-04 | 191 | 30 | 3 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.85e-04 | 192 | 30 | 3 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.85e-04 | 192 | 30 | 3 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.85e-04 | 192 | 30 | 3 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.90e-04 | 193 | 30 | 3 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 193 | 30 | 3 | d845beb0915a5b4bbd1e8f9b8d9322527a822849 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.90e-04 | 193 | 30 | 3 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.94e-04 | 194 | 30 | 3 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 2.99e-04 | 195 | 30 | 3 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.03e-04 | 196 | 30 | 3 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.08e-04 | 197 | 30 | 3 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 3.08e-04 | 197 | 30 | 3 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 3.08e-04 | 197 | 30 | 3 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | myeloid-Monocyte|myeloid / Lineage, cell class and subclass | 3.08e-04 | 197 | 30 | 3 | 6acf059cee6ba6bdeacc089b090d72336790972a | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 3.08e-04 | 197 | 30 | 3 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.12e-04 | 198 | 30 | 3 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 3.12e-04 | 198 | 30 | 3 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 3.12e-04 | 198 | 30 | 3 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.12e-04 | 198 | 30 | 3 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 3.12e-04 | 198 | 30 | 3 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.12e-04 | 198 | 30 | 3 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 3.12e-04 | 198 | 30 | 3 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-A_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.17e-04 | 199 | 30 | 3 | 09cf004032e5af912ee0cdde6e24ce3bcf7673cd | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.17e-04 | 199 | 30 | 3 | 119807ea333d1dc7743c6b9f03a2c63e09e19541 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.17e-04 | 199 | 30 | 3 | 691e04871cd6cac0ea5fca1b7fd6421df9315db6 | |
| ToppCell | severe-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.17e-04 | 199 | 30 | 3 | 50242666def13e5d4149c563ae000d6768f086f7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.17e-04 | 199 | 30 | 3 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.17e-04 | 199 | 30 | 3 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Sigmoid / Region, Cell class and subclass | 3.22e-04 | 200 | 30 | 3 | 9ee3a799de7bade1bfe94b6827461633f02bc1dc | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-Treg|Int-URO / Disease, condition lineage and cell class | 3.22e-04 | 200 | 30 | 3 | 47f265336bc3b8052c0cac730ac9afd41cd8fc43 | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 3.22e-04 | 200 | 30 | 3 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.22e-04 | 200 | 30 | 3 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.22e-04 | 200 | 30 | 3 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.22e-04 | 200 | 30 | 3 | a3f22826f3d8f917ff0594bdadd93b60763bcaa2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-04 | 200 | 30 | 3 | 38b51f337e183011e3ff32997ec26d8a424c6b78 | |
| ToppCell | severe-Myeloid-Neutrophils_4|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.22e-04 | 200 | 30 | 3 | b665f36dcf3c9d3981ee96f2973512f751612542 | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.22e-04 | 200 | 30 | 3 | 4943fe826d5fcc3dfeb8b99a7415848f3fecc994 | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 3.22e-04 | 200 | 30 | 3 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | Sigmoid-(6)_Macrophage-(60)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 3.22e-04 | 200 | 30 | 3 | ad84a83a5a1893f7b053d39eddeca851463a8ff0 | |
| Computational | Genes in the cancer module 236. | 2.64e-06 | 18 | 17 | 3 | MODULE_236 | |
| Drug | monatepil | 3.12e-20 | 29 | 30 | 9 | CID000060810 | |
| Drug | probucol | LRP1 LRP2 LRP3 LRP4 VLDLR LRP12 CD320 LRP10 LRP1B LDLR SORL1 | 8.16e-17 | 162 | 30 | 11 | CID000004912 |
| Drug | pitavastatin | 1.88e-14 | 114 | 30 | 9 | CID005282451 | |
| Drug | ezetimibe | 1.94e-13 | 147 | 30 | 9 | CID000150311 | |
| Drug | Epi Lovastatin | LRP1 LRP2 LRP3 LRP4 VLDLR LRP12 CD320 LRP10 LRP1B LDLR SORL1 | 3.07e-13 | 341 | 30 | 11 | CID000003962 |
| Drug | 25-hydroxycholesterol | 4.20e-13 | 160 | 30 | 9 | CID000065094 | |
| Drug | Calpain inhibitor I | 1.63e-12 | 280 | 30 | 10 | CID000004332 | |
| Drug | vitamin E | LRP1 LRP2 LRP3 LRP4 VLDLR LRP12 CD320 LRP10 LRP1B LDLR SORL1 | 4.99e-12 | 441 | 30 | 11 | CID000002116 |
| Drug | mangrove | 9.46e-12 | 468 | 30 | 11 | CID000000965 | |
| Drug | AC1L1J6H | 1.40e-11 | 236 | 30 | 9 | CID000004889 | |
| Drug | sodium cholate | 6.68e-11 | 408 | 30 | 10 | CID000000303 | |
| Drug | epicholesterol | LRP1 LRP2 LRP3 LRP4 VLDLR LRP12 CD320 LRP10 LRP1B LDLR SORL1 | 2.50e-10 | 636 | 30 | 11 | CID000000304 |
| Drug | sodium linoleate | 3.80e-10 | 342 | 30 | 9 | CID000003931 | |
| Drug | troglitazone | 7.89e-10 | 526 | 30 | 10 | CID000005591 | |
| Drug | simvastatin | 1.21e-09 | 390 | 30 | 9 | CID000054454 | |
| Drug | C6E3 | 8.52e-08 | 85 | 30 | 5 | CID000094362 | |
| Drug | isocycloheximide | 1.60e-06 | 905 | 30 | 9 | CID000002900 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 1.99e-06 | 160 | 30 | 5 | 6133_DN | |
| Drug | ethylnylestradiol | 2.65e-06 | 1251 | 30 | 10 | CID000003285 | |
| Drug | 17alpha-estradiol | 3.81e-06 | 1303 | 30 | 10 | CID000000450 | |
| Drug | cholesteryl ether | 4.10e-06 | 24 | 30 | 3 | CID000296867 | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; PC3; HT_HG-U133A | 4.62e-06 | 190 | 30 | 5 | 7145_UP | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; PC3; HT_HG-U133A | 5.65e-06 | 198 | 30 | 5 | 2107_UP | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 5.65e-06 | 198 | 30 | 5 | 1070_DN | |
| Drug | tetrahydroaldosterone-3-glucuronide | 7.37e-06 | 29 | 30 | 3 | CID000167918 | |
| Drug | N,N-dibenzylphenylethanolamine | 1.01e-05 | 4 | 30 | 2 | CID000048896 | |
| Drug | AC1NAL8H | 2.13e-05 | 41 | 30 | 3 | CID004478772 | |
| Drug | PD 109394 | 2.29e-05 | 42 | 30 | 3 | CID000059749 | |
| Drug | sterol | 2.31e-05 | 265 | 30 | 5 | CID000001107 | |
| Drug | AC1L9FMG | 3.51e-05 | 7 | 30 | 2 | CID000444053 | |
| Drug | benzamidine | 4.01e-05 | 147 | 30 | 4 | CID000002332 | |
| Drug | tesaglitazar | 4.22e-05 | 502 | 30 | 6 | ctd:C501413 | |
| Drug | cholesteryl linoleyl ether | 4.68e-05 | 8 | 30 | 2 | CID006438363 | |
| Drug | coprogen | 6.01e-05 | 9 | 30 | 2 | CID006323272 | |
| Drug | Urokinase | 7.50e-05 | 10 | 30 | 2 | DB00013 | |
| Drug | 25-azacoprostane | 7.50e-05 | 10 | 30 | 2 | CID000162243 | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 7.73e-05 | 174 | 30 | 4 | 864_UP | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 7.73e-05 | 174 | 30 | 4 | 972_UP | |
| Drug | dimyristoylphosphatidylcholine | 8.15e-05 | 64 | 30 | 3 | CID000026197 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; PC3; HT_HG-U133A | 1.04e-04 | 188 | 30 | 4 | 5921_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.06e-04 | 189 | 30 | 4 | 3788_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.11e-04 | 191 | 30 | 4 | 4303_DN | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.15e-04 | 193 | 30 | 4 | 1464_DN | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; PC3; HG-U133A | 1.15e-04 | 193 | 30 | 4 | 1896_UP | |
| Drug | Ursolic acid [77-52-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.15e-04 | 193 | 30 | 4 | 2067_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 1.18e-04 | 194 | 30 | 4 | 1060_UP | |
| Drug | 5707885; Up 200; 50uM; MCF7; HT_HG-U133A | 1.20e-04 | 195 | 30 | 4 | 6433_UP | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 1.20e-04 | 195 | 30 | 4 | 5269_DN | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 3896_UP | |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 5394_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 4739_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 5438_DN | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 2870_DN | |
| Drug | Budesonide [51333-22-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 5431_DN | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; PC3; HT_HG-U133A | 1.30e-04 | 199 | 30 | 4 | 4087_DN | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 1.30e-04 | 199 | 30 | 4 | 2822_UP | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.32e-04 | 200 | 30 | 4 | 2077_UP | |
| Drug | DuP 128 | 1.51e-04 | 14 | 30 | 2 | CID000071355 | |
| Drug | fenoxycarb | 1.58e-04 | 80 | 30 | 3 | CID000051605 | |
| Drug | T0901317 | 1.64e-04 | 81 | 30 | 3 | CID000447912 | |
| Drug | AC1L2GOW | 3.14e-04 | 20 | 30 | 2 | CID000046762 | |
| Drug | AC1MTXUO | 3.81e-04 | 22 | 30 | 2 | CID003632206 | |
| Drug | Leupeptin hydrochloride | 4.52e-04 | 276 | 30 | 4 | CID000003910 | |
| Drug | tristearin | 4.58e-04 | 277 | 30 | 4 | CID000011146 | |
| Disease | Alzheimer's disease (is_implicated_in) | 9.58e-06 | 132 | 30 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | adverse effect, response to xenobiotic stimulus | 2.97e-05 | 59 | 30 | 3 | EFO_0009658, GO_0009410 | |
| Disease | pack-years measurement, systolic blood pressure | 5.49e-04 | 34 | 30 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | blood urea nitrogen measurement | 1.09e-03 | 452 | 30 | 4 | EFO_0004741 | |
| Disease | melanoma | 2.01e-03 | 248 | 30 | 3 | C0025202 | |
| Disease | Abdominal Aortic Aneurysm | 2.18e-03 | 68 | 30 | 2 | EFO_0004214 | |
| Disease | Non-alcoholic Fatty Liver Disease | 2.31e-03 | 70 | 30 | 2 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 2.31e-03 | 70 | 30 | 2 | C3241937 | |
| Disease | migraine disorder, endometriosis | 2.51e-03 | 73 | 30 | 2 | EFO_0001065, MONDO_0005277 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QDWDECVDSAEHDCS | 506 | Q5DID0 | |
| EESCQTAAEGDNWCE | 36 | P11171 | |
| GCWCCRGDDVAESDD | 21 | Q6NSI1 | |
| SCDGDESDLWSCRNS | 651 | Q9NR16 | |
| DCSGARYNDWSDDDD | 51 | Q9UH62 | |
| GWTGEDCSENIDDCA | 326 | P46531 | |
| DQGCNSAECEWDGLD | 1546 | P46531 | |
| QRCDGSWDCADGTDE | 336 | Q7Z4F1 | |
| ESWVCDSQDDCGDGS | 466 | Q9Y561 | |
| RWKCDGDDDCLDGSD | 861 | Q9NZR2 | |
| WRCDGEKDCEDGSDE | 1071 | Q9NZR2 | |
| RFWCDGDFDCADGSD | 3531 | Q9NZR2 | |
| WVCDGEDDCGDNSDE | 3691 | Q9NZR2 | |
| CEDKEDDGDSCVECW | 506 | Q9H3C7 | |
| DDGDSCVECWANSEE | 511 | Q9H3C7 | |
| WKCDGDNDCLDNSDE | 871 | Q07954 | |
| RWLCDGDNDCGNSED | 911 | Q07954 | |
| ISWTCDLDDDCGDRS | 951 | Q07954 | |
| KAWVCDGDNDCEDNS | 1121 | Q07954 | |
| WVCDGANDCGDYSDE | 2671 | Q07954 | |
| WLCDGSDDCGDGSDE | 2751 | Q07954 | |
| RWLCDGDKDCADGAD | 2791 | Q07954 | |
| WECDGENDCHDQSDE | 2876 | Q07954 | |
| WKCDTEDDCGDHSDE | 3351 | Q07954 | |
| WVCDRDNDCVDGSDE | 3471 | Q07954 | |
| RWKCDGEDDCGDGSD | 3511 | Q07954 | |
| RWKCDGDHDCADGSD | 3591 | Q07954 | |
| WKCDGEDDCGDNSDE | 3671 | Q07954 | |
| TWRCDRDLDCSDGSD | 71 | Q9NPF0 | |
| EDHEDWASNGEEERC | 516 | Q6L8Q7 | |
| TWRCDGQEDCQDGSD | 471 | O75074 | |
| WVCDTDNDCGDGSDE | 1126 | P98164 | |
| EWKCDNDNDCGDGSD | 2716 | P98164 | |
| WQCDTFNDCEDNSDE | 3611 | P98164 | |
| AWKCDVDNDCGDHSD | 3651 | P98164 | |
| VCDDADDCGDWSDEL | 3946 | P98164 | |
| DWSGAEESDDENAVC | 1596 | P29375 | |
| WCDCGASGNRREDCE | 216 | Q9GZZ7 | |
| DLWCDGEADCSDSSD | 671 | Q9Y5Q5 | |
| GEADCSDSSDEWDCV | 676 | Q9Y5Q5 | |
| CDGWATCEDESDEAN | 51 | P98153 | |
| ACGNSNSWDKADEDD | 181 | Q8NAN2 | |
| VCDGDNDCRDWSDEA | 1176 | Q92673 | |
| WACDGDTDCQDGSDE | 1216 | Q92673 | |
| ENDCGDWSDEKDCGD | 1391 | Q92673 | |
| RGWRCDQEEDCADGS | 1581 | A2VEC9 | |
| QFGAECDEDAEDVWC | 166 | Q9UIK5 | |
| CNCSDSSDIELSDDW | 511 | Q9NRJ4 | |
| CRATAAWCTDSGSDD | 3316 | Q8IZQ1 | |
| CDGWADCTDHSDELN | 471 | Q9Y5Y6 | |
| WVCDSVNDCGDNSDE | 506 | Q9Y5Y6 | |
| FSCQVWPDDCDEDEE | 66 | Q9H497 | |
| SWRCDGENDCDSGED | 131 | P98155 | |
| WRCDGDPDCKDGSDE | 256 | P98155 | |
| ACDNDPDCEDGSDEW | 166 | P01130 | |
| RSWVCDGDNDCEDDS | 86 | O75096 | |
| DGDDDCGDWSDESDC | 211 | O75096 | |
| AGWRCDGDADCDDQS | 246 | O75096 | |
| SWRCDGEDDCADNSD | 286 | O75096 |